<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="modify">
            <roleset id="modify.01" name="" wordnet="3">
                <roles>
                    <role n="0" descr="agent, cause of transformation&#x0A;" />
                    <role n="1" descr="thing changing&#x0A;" />
                    <role n="2" descr="method&#x0A;" />
                    <role n="3" descr="consequence&#x09;&#x09;&#x09;&#x09;// secondary predication //&#x0A;" />
                </roles>
                <example src="EMBO" no="0">
                    <text>Taken together these data suggest that the SH3 acts to position the U5 region through its own association with the GUK domain and that factors that can modify the binding of either U5 or SH3 to the GUK domain may regulate GKAP binding to the GUK domain.</text>
                    <arg n="0">factors</arg>
                    <arg n="1">the binding of either U5 or SH3</arg>
                    <arg n="3">to the GUK domain</arg>
                    <arg n="M-MOD">can</arg>
                </example>
                <example src="EMBO" no="1">
                    <text>We have used the ability to modify P.falciparum genetically by transfection (Crabb and Cowman, 1996; Crabb et al., 1997a) to disrupt the RAP1 gene.</text>
                    <arg n="0">We</arg>
                    <arg n="1">P.falciparum</arg>
                    <arg n="2">by transfection</arg>
                    <arg n="3">to disrupt the RAP1 gene</arg>
                    <arg n="M-ADV">genetically</arg>
                </example>
                <example src="MEDLINE" no="1">
                    <text>To define the subcellular location of HVDAC isoforms, HVDAC genes were modified so that the encoded proteins contain COOH-terminal epitopes recognized by either of two monoclonal antibodies.</text>
                    <arg n="1">HVDAC genes</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
